N von Ahsen Selected Research

Continuous Positive Airway Pressure

6/2004

CPAP-therapy effectively lowers serum homocysteine in obstructive sleep apnea syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

N von Ahsen Research Topics

Disease

3	Multiple Sclerosis 01/2011 - 09/2009
3	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2008 - 12/2002
2	Brain Diseases (Brain Disorder) 01/2011 - 01/2004
2	Alcoholism (Alcohol Abuse) 04/2008 - 08/2000
1	Progressive Multifocal Leukoencephalopathy 01/2016
1	Protein S Deficiency (Deficiency, Protein S) 12/2011
1	Protein C Deficiency 12/2011
1	Activated Protein C Resistance (APC Resistance) 12/2011
1	Thrombophilia 12/2011
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2011
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2011
1	Central Nervous System Diseases (CNS Diseases) 01/2011
1	Encephalitis (Encephalitis, Rasmussen) 01/2011
1	Heart Failure 09/2009
1	Cardiomyopathies (Cardiomyopathy) 09/2009
1	Hyperhomocysteinemia 04/2008
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2008
1	Stroke (Strokes) 06/2004
1	Obstructive Sleep Apnea 06/2004
1	Cognitive Dysfunction 06/2004
1	Homocysteinemia 06/2004
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 06/2004
1	Kidney Neoplasms (Kidney Cancer) 01/2004
1	Psychotic Disorders (Schizoaffective Disorder) 01/2004
1	Schizophrenia (Dementia Praecox) 01/2004
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2004
1	alpha 1-Antitrypsin Deficiency (alpha 1 Antitrypsin Deficiency) 12/2002
1	Optic Nerve Diseases (Optic Neuropathy) 12/2002
1	Vascular System Injuries 12/2002
1	Hypoxia (Hypoxemia) 04/2001
1	Gilbert Disease 12/2000
1	Hyperbilirubinemia 12/2000
1	Thiopurine S methyltranferase deficiency 11/2000
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 10/2000
1	Thrombosis (Thrombus) 09/2000
1	Seizures (Absence Seizure) 08/2000
1	Alcohol Withdrawal Seizures 08/2000

Drug/Important Bio-Agent (IBA)

7	HomocysteineIBA 12/2011 - 08/2000
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2011 - 09/2009
2	Mitoxantrone (Novantrone)FDA LinkGeneric 09/2009 - 09/2009
2	Vitamin B Complex (B Vitamins)IBA 01/2008 - 01/2007
2	EnzymesIBA 12/2000 - 11/2000
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2016
1	Natalizumab (Tysabri)FDA Link 01/2016
1	AntithrombinsIBA 12/2011
1	Factor V (Coagulation Factor V)IBA 12/2011
1	factor V LeidenIBA 12/2011
1	Antiviral Agents (Antivirals)IBA 01/2011
1	Apolipoprotein E4IBA 04/2008
1	ApolipoproteinsIBA 04/2008
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2004
1	Erythropoietin FDA Link 01/2004
1	Haloperidol (Haldol)FDA LinkGeneric 01/2004
1	XenobioticsIBA 01/2004
1	Protease Inhibitors (Protease Inhibitor)IBA 12/2002
1	Peptide Hydrolases (Proteases)FDA Link 12/2002
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 12/2002
1	Dexamethasone (Maxidex)FDA LinkGeneric 04/2001
1	Endothelin-1 (Endothelin 1)IBA 04/2001
1	Endothelin-Converting EnzymesIBA 04/2001
1	Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA 12/2000
1	CreatinineIBA 10/2000
1	Immunoglobulin M (IgM)IBA 10/2000
1	Prothrombin (Factor II)IBA 09/2000
1	homocysteic acidIBA 08/2000
1	Neurotransmitter Agents (Neurotransmitter)IBA 08/2000
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 08/2000

Therapy/Procedure

2	Therapeutics 09/2009 - 06/2004
1	Continuous Positive Airway Pressure 06/2004